Research Triangle Park, North Carolina Saturday, February 15, 2025, 17:00 Hrs [IST] ...

Heart disease is more common in people over 65, but treatments are better than ever. That can complicate decision-making for older heart patients.

Bayer seeks Japanese marketing approval for finerenone to treat adult patients with chronic heart failure: Berlin Saturday, February 15, 2025, 14:00 Hrs [IST] Bayer announced the ...

The actress has been supporting calls for greater awareness of heart failure, which, according to the PHA, is a complex ...

Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart ...

The dual SGLT1/2 inhibitor sotagliflozin (Inpefa) reduced the risk for myocardial infarction (MI) and stroke in high-risk ...

Heart transplants are complex, costly, and risky—but for patients with heart failure, they are often the only option for ...

Infection-related hospitalization (IRH) is associated with incident heart failure, heart failure with preserved ejection ...

After surviving a life-threatening heart infection and undergoing emergency surgery, an Ontario man is celebrating both his recovery and his birthday on Valentine’s Day.

Researchers at the University of Toronto's Institute of Biomedical Engineering have found that studying blood flow in leg ...

New research explores how point-of-care lung ultrasound can improve prehospital identification of acute heart failure ...

A popular diabetes drug just got a major new approval — and it could be a game-changer for millions of Americans at risk for kidney failure.